CVC acquires Teva’s international women’s health assets
CVC Capital Partners has acquired pharmaceutical company Teva's non-US women’s health assets.
The transaction covers products sold in over 50 countries globally, for a cash value of $703m (€586.4m).
Headquartered in Israel, Teva is one of the world’s largest generic medicines...